PBYI PUMA BIOTECHNOLOGY INC Other Situations 8-K Filing 2023 - Acceptance of Trial at Conference Puma Biotechnology announced acceptance of a trial for the treatment of head and neck cancer at a conference.Get access to all SEC 8-K filings of the PUMA BIOTECHNOLOGY INC